Patterns of differential gene expression in a cellular model of human islet development, and relationship to type 2 diabetes predisposition
Open Access
- 19 April 2018
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 61 (7) , 1614-1622
Abstract
Aims/hypothesis Most type 2 diabetes-associated genetic variants identified via genome-wide association studies (GWASs) appear to act via the pancreatic islet. Observed defects in insulin secretion could result from an impact of these variants on islet development and/or the function of mature islets. Most functional studies have focused on the latter, given limitations regarding access to human fetal islet tissue. Capitalising upon advances in in vitro differentiation, we characterised the transcriptomes of human induced pluripotent stem cell (iPSC) lines differentiated along the pancreatic endocrine lineage, and explored the contribution of altered islet development to the pathogenesis of type 2 diabetes. Methods We performed whole-transcriptome RNA sequencing of human iPSC lines from three independent donors, at baseline and at seven subsequent stages during in vitro islet differentiation. Differentially expressed genes (q < 0.01, log2 fold change [FC] > 1) were assigned to the stages at which they were most markedly upregulated. We used these data to characterise upstream transcription factors directing different stages of development, and to explore the relationship between RNA expression profiles and genes mapping to type 2 diabetes GWAS signals. Results We identified 9409 differentially expressed genes across all stages, including many known markers of islet development. Integration of differential expression data with information on transcription factor motifs highlighted the potential contribution of REST to islet development. Over 70% of genes mapping within type 2 diabetes-associated credible intervals showed peak differential expression during islet development, and type 2 diabetes GWAS loci of largest effect (including TCF7L2; log2FC = 1.2; q = 8.5 × 10−10) were notably enriched in genes differentially expressed at the posterior foregut stage (q = 0.002), as calculated by gene set enrichment analyses. In a complementary analysis of enrichment, genes differentially expressed in the final, beta-like cell stage of in vitro differentiation were significantly enriched (hypergeometric test, permuted p value <0.05) for genes within the credible intervals of type 2 diabetes GWAS loci. Conclusions/interpretation The present study characterises RNA expression profiles during human islet differentiation, identifies potential transcriptional regulators of the differentiation process, and suggests that the inherited predisposition to type 2 diabetes is partly mediated through modulation of islet development. Data availability Sequence data for this study has been deposited at the European Genome-phenome Archive (EGA), under accession number EGAS00001002721.Keywords
Funding Information
- Russell Berrie Foundation
- European Union’s Seventh Framework Programme (FP7/2007-2013)
- Medical Research Council (MR/L020149/1)
- National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme
- Innovative Medicines Initiative (115439)
- Novo Nordisk
- Wellcome (H5R00430)
This publication has 51 references indexed in Scilit:
- Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetesDiabetologia, 2017
- Induced pluripotent stem cell modelling of HLHS underlines the contribution of dysfunctional NOTCH signalling to impaired cardiogenesisHuman Molecular Genetics, 2017
- Insights into islet development and biology through characterization of a human iPSC-derived endocrine pancreas modelIslets, 2016
- Transcript Expression Data from Human Islets Links Regulatory Signals from Genome-Wide Association Studies for Type 2 Diabetes and Glycemic Traits to Their Downstream EffectorsPLOS Genetics, 2015
- Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cellsNature Biotechnology, 2014
- The transcriptional landscape of mouse beta cells compared to human beta cells reveals notable species differences in long non-coding RNA and protein-coding gene expressionBMC Genomics, 2014
- Characterization of polyhormonal insulin-producing cells derived in vitro from human embryonic stem cellsStem Cell Research, 2014
- Dynamic Chromatin Remodeling Mediated by Polycomb Proteins Orchestrates Pancreatic Differentiation of Human Embryonic Stem CellsCell Stem Cell, 2013
- LMNA Mutations, Skeletal Muscle Lipid Metabolism, and Insulin ResistanceThe Journal of Clinical Endocrinology & Metabolism, 2010
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005